{"count": 2, "results": [{"_id": "9449436", "pmid": 9449436, "title": "Concurrent blockade of beta-adrenergic and muscarinic receptors suppresses synergistically long-term potentiation of population spikes in the rat hippocampal CA1 region.", "journal": "Brain Res", "authors": ["Kobayashi M", "Ohno M", "Shibata S", "Yamamoto T", "Watanabe S"], "date": "1997-11-28T00:00:00Z", "doi": "10.1016/s0006-8993(97)01212-2", "meta_date_publication": "1997 Nov 28", "meta_volume": "777", "meta_issue": "1-2", "meta_pages": "242-6", "score": 50063.715, "text_hl": "On the other hand, the coapplication of @CHEMICAL_Scopolamine @CHEMICAL_MESH:D012601 @@@scopolamine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ failed to affect @<m>DISEASE_Tetany</m> @DISEASE_MESH:D013746 @@@tetanus@@@-induced LTP of field EPSP. ", "citations": {"NLM": "Kobayashi M, Ohno M, Shibata S, Yamamoto T, Watanabe S. Concurrent blockade of beta-adrenergic and muscarinic receptors suppresses synergistically long-term potentiation of population spikes in the rat hippocampal CA1 region. Brain Res. 1997 Nov 28;777(1-2):242-6. PMID: 9449436", "BibTeX": "@article{9449436, title={Concurrent blockade of beta-adrenergic and muscarinic receptors suppresses synergistically long-term potentiation of population spikes in the rat hippocampal CA1 region.}, author={Kobayashi M and Ohno M and Shibata S and Yamamoto T and Watanabe S}, journal={Brain Res}, volume={777}, number={1-2}, pages={242-6}}"}}, {"_id": "2873272", "pmid": 2873272, "title": "Long-term follow-up of mitral valve prolapse and latent tetany. Preliminary data.", "journal": "Magnesium", "authors": ["Frances Y", "Collet F", "Luccioni R"], "date": "1986-01-01T00:00:00Z", "meta_date_publication": "1986", "meta_volume": "5", "meta_issue": "3-4", "meta_pages": "175-81", "score": 50052.17, "text_hl": "After showing the failure of short-term therapy (1-3 months), we found 12 cases treated for more than 1 year, having @DISEASE_Mitral_Valve_Prolapse @DISEASE_MESH:D008945 @@@MVP@@@, @DISEASE_Hyperkinesis @DISEASE_MESH:D006948 @@@LVH@@@ and @<m>DISEASE_Tetany</m> @DISEASE_MESH:D013746 @@@LT@@@. The mean duration of this continuous therapy was 36.5 months (range 12-72 months). 5 @SPECIES_9606 @@@men@@@ and 7 @SPECIES_9606 @@@women@@@ (mean age 49; range 28-70) received magnesium salts (pyrrolidone carboxylate 4.5 g/day, @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ 3 g/day) either alone (2 cases) or associated with a beta-blocker (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 100 mg/day, @CHEMICAL_Acebutolol @CHEMICAL_MESH:D000070 @@@acebutolol@@@ 200-400 mg/day, @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, 40-160 mg/day; 10 cases). ", "citations": {"NLM": "Frances Y, Collet F, Luccioni R. Long-term follow-up of mitral valve prolapse and latent tetany. Preliminary data. Magnesium. 1986;5(3-4):175-81. PMID: 2873272", "BibTeX": "@article{2873272, title={Long-term follow-up of mitral valve prolapse and latent tetany. Preliminary data.}, author={Frances Y and Collet F and Luccioni R}, journal={Magnesium}, volume={5}, number={3-4}, pages={175-81}}"}}]}